Diabetes medication choice decision aid
WebJan 14, 2016 · The interactive Diabetes Decision Aid for T2DM targeted decisions about antihyperglycemic medication intensification for subjects for whom first-line treatment with metformin is no longer effective. ... Future studies should assess the impact of PDA on medication choice, medication adherence, patient-provider communication, glycemic … WebAug 10, 2024 · The statin choice decision aid and the diabetes medication choice decision aid. The SCDA and DMCDA were developed at the Mayo Clinic to encourage …
Diabetes medication choice decision aid
Did you know?
WebNov 14, 2016 · Objective: To assess the efficacy of the Diabetes Medication Choice Decision Aid among patients with type 2 diabetes in Greece. Design: Open-label … WebAug 8, 2013 · Background Patient-centered diabetes care requires shared decision making (SDM). Decision aids promote SDM, but their efficacy in nonacademic and rural primary care clinics is unclear. Methods We cluster-randomized 10 practices in a concealed fashion to implement either a decision aid (DA) about starting statins or one about choosing …
WebApr 1, 2016 · The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes. ... Diabetes medication choice—typical patient [video on the Internet]. WebOct 15, 2009 · The Diabetes Medication Choice decision aid cards were used to help patients and their clinician reach a decision regarding their course of care. The cards were created by an innovative team of ...
WebMay 28, 2012 · The Diabetes Medication Choice decision aid takes the form of cards that compare commonly used diabetes medication classes across several domains (e.g., reduction in HbA1c, weight gain, cost, mode of administration) that patients with type 2 diabetes and clinicians consider important when choosing these medications [7, 8].
WebThe Diabetes Medication Choice Decision Aid has been previously assessed in two cluster randomised trials enrolling rural and suburban primary care practices in the USA.14, 16 Similarly to our study, clinicians …
WebDec 9, 2009 · Primary care practices were enrolled then matched by size (less than or equal to 2 clinicians or greater than 2 clinicians) and randomly allocated by a statistician to 1) the use of the Diabetes Medication Choice decision aid and usual care for lipid therapy medication (statin) discussion during the encounter with subjects or to 2) the use of ... shutdown redémarrerWebOct 13, 2006 · No. Criteria. Have a diagnosis of type 2 diabetes mellitus of any duration; c-peptide test not required. Use 1 or 2 oral hypoglycemic agents; not using insulin therapy. … thep353WebOct 15, 2009 · The Diabetes Mellitus Medication Choice Decision Aid: A Randomized Trial. Archives of Internal Medicine , 2009; 169 (17): 1560 DOI: 10.1001/archinternmed.2009.293 Cite This Page : thep352WebFor example, the Diabetes Medication Choice Decision Aid helps patients and their providers choose among the six medications commonly used to treat type-2 diabetes. … thep352.ccWebApr 30, 2015 · In its most recent Standards of Medical Care in Diabetes, the American Diabetes Association (ADA) emphasized a patient-centered approach to determine treatment selection when choosing medications added to metformin. 2 The ADA recommends physicians use an approach that ensures that patients understand the … thep351.ccWebThe statin choice decision aid was tested regarding statin adherence in a specialised clinic,14 one primary care centre13 and several primary care practices in Spain.15 Improvement of adherence was only found in the specialised clinic.14 The diabetes medication choice decision aid had no impact on adherence,17 while one study even … thep354WebSep 28, 2009 · Background: Patient involvement in the choice of antihyperglycemic agents could improve adherence and optimize glycemic control in patients with type 2 diabetes … thep355